These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 18837075)
21. Genetic association studies in ischaemic stroke: replication failure and prospects. Pruissen DM; Kappelle LJ; Rosendaal FR; Algra A Cerebrovasc Dis; 2009; 27(3):290-4. PubMed ID: 19202334 [TBL] [Abstract][Full Text] [Related]
22. Why, when, and how should pharmacogenetics be applied in clinical studies?: current and future approaches to study designs. Stingl Kirchheiner JC; Brockmöller J Clin Pharmacol Ther; 2011 Feb; 89(2):198-209. PubMed ID: 21209614 [TBL] [Abstract][Full Text] [Related]
25. Using genotyping to predict responses to anti-hypertensive treatment. Kurland L; Lind L; Melhus H Trends Pharmacol Sci; 2005 Sep; 26(9):443-7. PubMed ID: 16055200 [TBL] [Abstract][Full Text] [Related]
26. Improving the conduct of epidemiologic studies: an introduction to quality principles. Acquavella JF J Occup Med; 1991 Dec; 33(12):1244-6. PubMed ID: 1800682 [TBL] [Abstract][Full Text] [Related]
27. DNA cards: determinants of DNA yield and quality in collecting genetic samples for pharmacogenetic studies. Mas S; Crescenti A; Gassó P; Vidal-Taboada JM; Lafuente A Basic Clin Pharmacol Toxicol; 2007 Aug; 101(2):132-7. PubMed ID: 17651316 [TBL] [Abstract][Full Text] [Related]
28. Multidimensional assessment of quality of life in clinical studies. Jalowiec A Prog Cardiovasc Nurs; 1992; 7(1):7-12. PubMed ID: 1518783 [TBL] [Abstract][Full Text] [Related]
29. Ancillary risk information and pharmacogenetic tests: social and policy implications. Henrikson NB; Burke W; Veenstra DL Pharmacogenomics J; 2008 Apr; 8(2):85-9. PubMed ID: 17486108 [TBL] [Abstract][Full Text] [Related]
30. [Pharmacogenetic testing: soon before every prescription?]. Buclin T; Colombo S; Biollaz J Rev Med Suisse; 2008 Jul; 4(165):1666-70. PubMed ID: 18767293 [TBL] [Abstract][Full Text] [Related]
31. The quality of reporting of randomized controlled trials in solid organ transplantation. Pengel LH; Barcena L; Morris PJ Transpl Int; 2009 Apr; 22(4):377-84. PubMed ID: 19000234 [TBL] [Abstract][Full Text] [Related]
32. Interpreting P values in pharmacogenetic studies: a call for process and perspective. Maitland ML; Ratain MJ; Cox NJ J Clin Oncol; 2007 Oct; 25(29):4513-5. PubMed ID: 17925544 [No Abstract] [Full Text] [Related]
33. A neurologist's guide to genome-wide association studies. Mullen SA; Crompton DE; Carney PW; Helbig I; Berkovic SF Neurology; 2009 Feb; 72(6):558-65. PubMed ID: 19204266 [TBL] [Abstract][Full Text] [Related]
34. [Pharmacogenetic aspects of current pharmacotherapy]. Slanar O; Zima T Cas Lek Cesk; 2010; 149(10):472-5. PubMed ID: 21121137 [TBL] [Abstract][Full Text] [Related]
35. Hypotheses, tests, methods, and innovation: the balancing act in research. Berg AT Epilepsia; 2007 Dec; 48(12):2204-16. PubMed ID: 17868050 [TBL] [Abstract][Full Text] [Related]
36. Pharmacogenomics and therapeutic strategies for dementia. Cacabelos R Expert Rev Mol Diagn; 2009 Sep; 9(6):567-611. PubMed ID: 19732004 [TBL] [Abstract][Full Text] [Related]
37. [Role of genetics in anaesthesia-related variability]. Textoris J; Davidson J; Martin C; Leone M Ann Fr Anesth Reanim; 2009 Jun; 28(6):564-74. PubMed ID: 19539443 [TBL] [Abstract][Full Text] [Related]
38. Pharmacogenetics in chemotherapy of colorectal cancer. Henriette Tanja L; Guchelaar HJ; Gelderblom H Best Pract Res Clin Gastroenterol; 2009; 23(2):257-73. PubMed ID: 19414151 [TBL] [Abstract][Full Text] [Related]
39. Pharmacogenetics and drug development: the path to safer and more effective drugs. Roses AD Nat Rev Genet; 2004 Sep; 5(9):645-56. PubMed ID: 15372086 [TBL] [Abstract][Full Text] [Related]